nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anthracycline Chemotherapy and Cardiotoxicity
|
McGowan, John V |
|
2017 |
31 |
1 |
p. 63-75 |
artikel |
2 |
Cardioprotection: Where to from here?
|
Kloner, Robert A. |
|
2016 |
31 |
1 |
p. 53-61 |
artikel |
3 |
CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness Analysis
|
Jiang, Minghuan |
|
2016 |
31 |
1 |
p. 39-49 |
artikel |
4 |
Editorial to: “Building a Bridge to the Future of Cardiovascular Drugs and Therapy”
|
Davidson, Sean M |
|
2017 |
31 |
1 |
p. 51-52 |
artikel |
5 |
Exosomes and Cardiovascular Protection
|
Davidson, Sean M. |
|
2016 |
31 |
1 |
p. 77-86 |
artikel |
6 |
Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction
|
Chen, Leilei |
|
2016 |
31 |
1 |
p. 9-18 |
artikel |
7 |
Mitochondrial-Shaping Proteins in Cardiac Health and Disease – the Long and the Short of It!
|
Ong, Sang-Bing |
|
2017 |
31 |
1 |
p. 87-107 |
artikel |
8 |
Next-Generation Stem Cell Therapy: Genetically Modified Mesenchymal Stem Cells for Cardiac Repair
|
Kulandavelu, Shathiyah |
|
2017 |
31 |
1 |
p. 5-7 |
artikel |
9 |
Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?
|
Borah, Bijan J. |
|
2017 |
31 |
1 |
p. 1-3 |
artikel |
10 |
Protein Quality Control Dysfunction in Cardiovascular Complications Induced by Anti-Cancer Drugs
|
Fu, Hai Ying |
|
2017 |
31 |
1 |
p. 109-117 |
artikel |
11 |
Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype
|
Rogers, Russell G. |
|
2017 |
31 |
1 |
p. 29-38 |
artikel |
12 |
Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation
|
Dai, Yao |
|
2017 |
31 |
1 |
p. 19-27 |
artikel |